Tele-group CBT for families of people with schizophrenia
Official title: Effectiveness of a Tele-group Cognitive Behavioural Family Intervention (tgCBFI) for People With Schizophrenia and Their Families: a Mixed-method Study
Run by The Hong Kong Polytechnic University · NCT07121166 · Data updated 2026-11-12
A online group program tests whether a family-based cognitive behavioral intervention delivered to people with schizophrenia and their family members can help reduce caregiver stress and improve symptoms for patients.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 64 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | The Hong Kong Polytechnic University Academic / other |
| Locations | 6 sites (Chai Wan and 5 other locations) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | May 31, 2028 |
| Study ends | July 31, 2028 |
| Registry record updated | July 24, 2026 |
| Trial ID | NCT07121166 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with schizophrenia-spectrum disorders (18-64) who can read and write Chinese and live with a family caregiver able to participate.
✕Probably not a fit
Individuals who do not have a participating family caregiver or cannot meet language and living arrangement criteria may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study uses a mixed-methods design to test a tele-delivered cognitive behavioral family intervention (tgCBFI) for dyads of individuals with schizophrenia and their family caregivers. It includes a randomized controlled trial with a 12-week post-intervention follow-up and qualitative focus groups to understand perceived benefits. The trial compares tgCBFI plus treatment as usual to treatment as usual alone, measuring caregiver mood and burden, patient expressed emotion, and patient symptom changes. Quantitative outcomes will be complemented by qualitative data from service users and caregivers to provide deeper insight into how the intervention works. The study builds on evidence that family interventions can reduce relapse risk and caregiver distress by addressing cognitive reactions and family dynamics.
Why it matters
Potential benefit: If successful, participants could experience reduced caregiver burden and mood disturbances, and patients may show lower expressed emotion and symptom severity.
How similar studies have gone: Previous meta-analyses support family interventions for relapse prevention and caregiver well-being, suggesting potential benefit for this tele-delivered approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
I. Individuals with schizophrenia-spectrum disorders Inclusion Criteria: * current diagnosis of schizophrenia-spectrum disorders, based on ICD-10 made by the treating clinicians, * aged 18-64, and * able to read and write Chinese Exclusion Criteria: * having co-morbidity of learning disability, organic/neurological conditions, or substance use disorder, and * living in a hostel II. Family caregivers Inclusion Criteria: * aged 18 or above, * able to read and write Chinese, * live with service users, and * nominated by the service users Exclusion Criteria: * having active psychiatric conditions
Where it's running
-
ALOHA (Eastern)
Chai Wan, Hong Kong Recruiting -
Kowloon Hospital
Kowloon City, Hong Kong Recruiting -
Kwai Chung Hospital
Kwai Chung, Hong Kong Recruiting -
United Christian Hospital
Kwun Tong, Hong Kong Recruiting -
Queen Mary Hospital
Pokfulam, Hong Kong Recruiting -
ALOHA (Wong Tai Sin)
Tsz Wan Shan, Hong Kong Recruiting
Study contacts
- Principal investigator: Dennis Chak Fai Ma, PhD — School of Nursing, The Hong Kong Polytechnic University
- Study coordinator: Dennis Chak Fai Ma, PhD
- Email: dennis.cf.ma@polyu.edu.hk
- Phone: 852-27666555
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Social isolation and aging in people with schizophrenia
This project will test whether long-term social isolation helps explain faster physical aging in people aged 40–70 with schizophrenia who took part in earlier research.
-
SPARK Healthy Sleep: a single-session app program to improve sleep for college students at risk for psychosis.
This program tests whether a 30-minute smartphone session can improve sleep and reduce stigma in Indiana University college students who report psychotic-like experiences.
-
Bilateral prefrontal and insular TMS to treat depression in schizophrenia.
This trial will try repetitive transcranial magnetic stimulation (rTMS) with an H4 coil over both prefrontal and insular brain areas to see if it reduces depressive symptoms in adults with schizophrenia.
-
Comparing two types of exercise therapy for mental disorders
This study is testing whether a standard high-intensity workout or a shorter, easier version is better for improving mental health in people with schizophrenia or bipolar disorder.
-
MitoQ treatment for early-phase schizophrenia and cognitive issues
This study is testing if MitoQ, an antioxidant, can improve thinking skills in young adults with early-phase schizophrenia who have problems with their brain's energy production.
-
Comparing Avatar Therapy and Cognitive Behavioural Therapy for Hearing Voices
This study is testing whether Avatar Therapy can help people with long-term hearing voices feel better compared to standard Cognitive Behavioural Therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.